Search Market Research Report
Stroke Management Market Size, Share Global Analysis Report, 2023 – 2030
Stroke Management Market Size, Share, Growth Analysis Report By End User (Research Institutes, Rehabilitation Centers, Diagnostic Centers, Ambulatory Surgical Centers, Hospitals, And Others), By Treatment (Rehabilitation Therapy, Surgical Interventions, And Medications), By Diagnosis (Brain Scans, Imaging Tests, Blood Tests, And Physical Examinations), By Application (Transient Ischemic Attack, Hemorrhagic Stroke, And Ischemic Stroke), By Type (Echocardiography, Electrocardiography, Cerebral Angiography, Carotid Ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT scan)), And By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 – 2030
Industry Insights
[208+ Pages Report] According to Facts and Factors, the global stroke management market size was valued at USD 36.46 billion in 2022 and is predicted to surpass USD 59.14 billion by the end of 2023. The stroke management industry is expected to grow by a CAGR of 6.27%.
Market Overview
A stroke is a cerebrovascular accident that disturbs the consistent blood supply to the brain. Stroke management refers to the healthcare practices and strategies for diagnosing, treating, preventing, and offering rehabilitation medication for patients with stroke. Stroke management requires expert healthcare professionals like radiologists, emergency physicians, neurologists, and rehabilitation specialists to offer comprehensive care to the patients.
Key Insights
- As per the analysis shared by our research analyst, the global stroke management market size is estimated to grow annually at a CAGR of around 6.27% over the forecast period (2023-2030).
- In terms of revenue, the global stroke management market size was valued at around USD 36.46 billion in 2022 and is projected to reach USD 59.14 billion by 2030.
- Public awareness and education are driving the growth of the global stroke management market.
- Based on the end users, the hospital segment is growing at a high rate and is projected to dominate the global market.
- Based on the treatment, the medication segment is projected to swipe the largest market share.
- Based on the diagnosis, the imaging tests segment is the fastest-growing segment in the global market.
- Based on the application, the ischemic stroke segment is anticipated to grow with a high CAGR in the global market.
- Based on the type, the computed tomography scan (CT scan) segment is projected to swipe the largest market share.
- Based on region, North America is expected to dominate the global market during the forecast period.
Growth Drivers
- Public awareness and education are likely to drive the growth of the global market.
The surging awareness among people regarding stroke risk factors and symptoms is one of the major factors driving the growth of the global stroke management market. Also, the awareness regarding early recognition and treatment is further promoting industry growth.
Additionally, the multidisciplinary approach to stroke management is further inducing comprehensive care and treatment for stroke patients. The world is witnessing a global aging population, which has significantly raised their vulnerability to stroke. The increasing incidences of lifestyle-induced diseases like obesity, thyroid, BP, and hypertension are also increasing stroke cases.
For instance, Integer Holdings Corporation successfully took over Oscor Inc. in December 2021. The major goal of this deal is to help the latter expand its product portfolio in the field of neurostimulation and cardiovascular devices.
Restraints
- High cost of treatment is likely to hamper the growth of the global market.
Stroke management is quite expensive. It includes acute care settings and advanced treatments like mechanical thrombectomy, which poses a high financial risk to stroke patients. Also, chronic conditions like hypertension, diabetes, and obesity further slowdown the growth of the stroke management industry.
Opportunities
- Emergence of telemedicine and remote consultations is expected to foster growth opportunities in the global market.
Healthcare professionals are expanding the scope of telemedicine and coming up with telestroke programs, which are likely to foster growth opportunities in the global stroke management market. This strategy has expanded the scope of the market in underserved and remote areas.
Also, the increasing investments in healthcare infrastructure are also likely to support the growth trajectory of the industry. Advanced diagnostic tools and medical treatment have significantly enhanced the patient experience in healthcare facilities. For instance, Qure.ai is collaborating with Siemens Healthineers to come up with chest X-ray AI rollout TB screening. It will help healthcare professionals to diagnose the infectious disease in the early stages.
Challenges
- Rural healthcare is a big challenge in the global market.
Rural areas face more healthcare challenges because of the lack of proper healthcare infrastructure. Also, in the case of emergencies, it takes a longer time to travel to big healthcare facilities offering specialized stroke management. Moreover, the limited medicine infrastructure is also anticipated to negatively impact the growth trajectory of the stroke management industry.
Segmentation Analysis
The global stroke management market can be segmented into end user, treatment, diagnosis, application, type, and region.
By end users, the market can be segmented into research institutes, rehabilitation centers, diagnostic centers, ambulatory surgical centers, hospitals, and others. The hospital segment accounts for the largest share of the stroke management industry.
Hospitals are well equipped with advanced machinery and diagnostic tools for the comprehensive care of stroke patients. Surgical interventions and rehabilitation services are also available in the hospital centers in case of emergency.
Therefore, this one-stop approach is one of the primary reasons for the growth of the segment. These centers are often given a dedicated professional team for stroke units. Hospitals hold a team of medical specialists like radiologists, neurosurgeons, rehabilitation therapists, etc., who can contribute immensely towards the best care for stroke patients. Moreover, the 24×7 services offered by hospitals are another major reason for the high growth rate of the segment.
By treatment, the market can be segmented into rehabilitation therapy, surgical interventions, and medications. The medication segment is projected to witness notable growth in the forthcoming years. Increasing public awareness regarding the importance of identifying stroke symptoms in the early stages and seeking immediate medical care is fostering growth opportunities in the segment.
Furthermore, the ongoing research and development activities in the pharmaceutical sector are expected to result in advanced medications for effective stroke management. Therefore, such a landscape is likely to boost the growth of the segment.
By diagnosis, the stroke management industry can be segmented into brain scans, imaging tests, blood tests, and physical examinations. The imaging tests segment swipes the largest share of the global market. Imaging tests offer detailed and accurate insights regarding the brain status, thereby helping medical specialists recognize the problematic location and check out the scope of blockages.
Moreover, imaging tests are very quick, thereby helping in times of sensitive decisions in case of stroke. It is more crucial in thrombolytics. Such a landscape is expected to widen the scope of the segment in the forthcoming years.
By application, the market can be segmented into transient ischemic attack, hemorrhagic stroke, and ischemic stroke. Ischemic stroke is the fastest-growing segment in the global stroke management market. The high prevalence of ischemic strokes, which is around 85% of all stroke cases, is the primary reason for the high growth rate of the segment.
The ongoing research activities in thrombolytic therapies have proved to be advantageous for ischemic stroke. Thrombolytic therapies help in treating these ischemic strokes effectively. However, lifestyle factors like obesity, diabetes, and blood pressure are further contributing to the high incidences of ischemic strokes.
By type, the market can be segmented into echocardiography, electrocardiography, cerebral angiography, carotid ultrasound, magnetic resonance imaging (MRI), and computed tomography scan (CT scan). The computed tomography scan (CT scan) segment is expected to dominate the global market during the forecast period.
CT scans are crucial in the diagnosis of stroke patients. These scans can be performed quickly and, therefore, help in determining the ideal treatment for the patient in case of an emergency or time-sensitive window. Also, these scans are easily available in hospitals and other medical facilities, thereby helping patients in case of emergencies.
Report Scope
Report Attribute |
Details |
Market Size in 2022 |
USD 36.46 Billion |
Projected Market Size in 2030 |
USD 59.14 Billion |
CAGR Growth Rate |
6.27% CAGR |
Base Year |
2022 |
Forecast Years |
2023-2030 |
Key Market Players |
Medtronic, Abbott Laboratories, Stryker Corporation, Bayer AG, Philips Healthcare, Siemens Healthineers, Johnson & Johnson, Biogen, Boston Scientific, Penumbra Inc., NeuroLogica Corporation, Boehringer Ingelheim, Genentech, Daiichi Sankyo, Nihon Kohden, and Others. |
Key Segment |
By End User, By Treatment, By Diagnosis, By Application, By Type, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
- North America to dominate the global market during the projected timeline.
North America is projected to witness notable growth in the global stroke management market during the forthcoming years due to the increasing incidence of stroke in the region. Moreover, the aging population and the hectic lifestyle of people are inducing obesity, diabetes, and hypertension among individuals, which is further making them more vulnerable to stroke. The region witnesses a high growth rate also because of the presence of well-established health infrastructure in the region.
The region holds a strong network of specialized stroke centers, ambulatory centers, surgical centers, diagnostic centers, clinics, and high hospitals. Each medical unit is well-equipped with the latest technology for stroke management and diagnosis. The region is making advancements in remote healthcare services and telemedicine, which is further expected to foster growth opportunities in the global stroke management market.
Asia Pacific is also expected to witness a steady growth rate in the forthcoming years because of the increasing public health campaigns to create awareness regarding stroke risk factors and symptoms among people. Moreover, the surging awareness among people regarding regular health checkups, preventive care practices, and lifestyle changes is further likely to foster growth opportunities in the regional market.
For instance, Abbott came up with a unique vascular imaging platform in 2023 in India. The platform is powered by Ultreon 1.0 Software. It combines AI with optical coherence tomography (OCT) and provides a detailed view of blockages and blood flow in the arteries.
Competitive Analysis
The key players in the global stroke management market include:
- Medtronic
- Abbott Laboratories
- Stryker Corporation
- Bayer AG
- Philips Healthcare
- Siemens Healthineers
- Johnson & Johnson
- Biogen
- Boston Scientific
- Penumbra Inc.
- NeuroLogica Corporation
- Boehringer Ingelheim
- Genentech
- Daiichi Sankyo
- Nihon Kohden
The global stroke management market is segmented as follows:
By End User Segment Analysis
- Research Institutes
- Rehabilitation Centers
- Diagnostic Centers
- Ambulatory Surgical Centers
- Hospitals
- Others
By Treatment Segment Analysis
- Rehabilitation Therapy
- Surgical Interventions
- Medications
By Diagnosis Segment Analysis
- Brain Scans
- Imaging Tests
- Blood Tests
- Physical Examinations
By Application Segment Analysis
- Transient Ischemic Attack
- Hemorrhagic Stroke
- Ischemic Stroke
By Type Segment Analysis
- Echocardiography
- Electrocardiography
- Cerebral Angiography
- Carotid Ultrasound
- Magnetic Resonance Imaging (MRI)
- Computed Tomography Scan (CT scan)
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Medtronic
- Abbott Laboratories
- Stryker Corporation
- Bayer AG
- Philips Healthcare
- Siemens Healthineers
- Johnson & Johnson
- Biogen
- Boston Scientific
- Penumbra Inc.
- NeuroLogica Corporation
- Boehringer Ingelheim
- Genentech
- Daiichi Sankyo
- Nihon Kohden
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors